ArticleEuropean journal of human genetics : EJHG2025

Variable response of germline activating PDGFRB variants to receptor tyrosine kinase inhibitors: implications for treatment.

Ileana Cristea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.